Researcher.Life Logo

FASEB Journal : Impact Factor & More

eISSN: 1530-6860pISSN: 0892-6638

Key Metrics

CiteScore
7.9
Impact Factor
< 5
Scite Index
0.94 5-Year SI
SNIP
1.1
Recommended pre-submission checks
Powered by Paperpal by Editage

FASEB Journal Journal Specifications

Overview
Publisher WILEY
Language English
Frequency Article-by-article
General Details
LanguageEnglish
FrequencyArticle-by-article
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in FASEB Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in FASEB Journal

Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP-43 Mouse Model of Frontotemporal Dementia.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Deficiency of Pdap1 Results in Embryonic Lethality and Diminished Vascularization.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Anti-TP0136 Antibody Delayed Syphilis Wound Healing by Inhibiting Angiogenesis Through the VEGF-A Signaling Pathway: A Novel View in Nonhealing Syphilis Wounds.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
C-X-C Motif Chemokine Ligand 3 as a Potential Biomarker for Diagnosis and Prognosis of Diabetic Kidney Disease.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Combatting Silicosis Fibrosis: Methyl Gallate Suppresses Pathogenic Fibroblasts Through hnRNPA2/B1-MDM4-P53 Network Disruption.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Molecular Therapy for Non-Alcoholic Fatty Liver Disease: Angiotensin-(1-7) Delivery via Cyclic RGD-Modified Vesicles Activates Mas Receptor to Ameliorate Fibrosis Through Autophagy and Metabolic Reprogramming.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Defining the Intestinal eCBome and Oxylipin Signaling Systems in a TDP-43 Mouse Model of Frontotemporal Dementia.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Deficiency of Pdap1 Results in Embryonic Lethality and Diminished Vascularization.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Anti-TP0136 Antibody Delayed Syphilis Wound Healing by Inhibiting Angiogenesis Through the VEGF-A Signaling Pathway: A Novel View in Nonhealing Syphilis Wounds.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
C-X-C Motif Chemokine Ligand 3 as a Potential Biomarker for Diagnosis and Prognosis of Diabetic Kidney Disease.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Combatting Silicosis Fibrosis: Methyl Gallate Suppresses Pathogenic Fibroblasts Through hnRNPA2/B1-MDM4-P53 Network Disruption.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Molecular Therapy for Non-Alcoholic Fatty Liver Disease: Angiotensin-(1-7) Delivery via Cyclic RGD-Modified Vesicles Activates Mas Receptor to Ameliorate Fibrosis Through Autophagy and Metabolic Reprogramming.
  • 31 Jan 2026
  • FASEB journal : official publication of the Federation of American Societies for Experimental Biology

FAQs on FASEB Journal